KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,000 | -88.0% | 67,015 | -44.1% | 0.00% | – |
Q1 2022 | $166,000 | +654.5% | 119,963 | +552.8% | 0.00% | – |
Q4 2021 | $22,000 | -63.9% | 18,376 | -21.1% | 0.00% | – |
Q3 2021 | $61,000 | -91.1% | 23,300 | -82.0% | 0.00% | – |
Q2 2021 | $687,000 | -44.7% | 129,644 | -29.7% | 0.00% | – |
Q1 2021 | $1,243,000 | +25.8% | 184,383 | +26.5% | 0.00% | – |
Q4 2020 | $988,000 | +80.6% | 145,800 | +99.9% | 0.00% | – |
Q3 2020 | $547,000 | -43.8% | 72,953 | -21.3% | 0.00% | – |
Q2 2020 | $974,000 | +98.8% | 92,738 | +66.5% | 0.00% | – |
Q1 2020 | $490,000 | – | 55,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 771,790 | $5,788,000 | 5.46% |
RA Capital Management | 10,874,613 | $81,560,000 | 1.49% |
Mesirow Financial Investment Management, Inc. | 36,445 | $273,000 | 1.17% |
Samsara BioCapital, LLC | 451,162 | $3,384,000 | 0.94% |
Parkman Healthcare Partners LLC | 310,053 | $2,325,000 | 0.62% |
Orbimed Advisors | 5,465,030 | $40,988,000 | 0.52% |
Eventide Asset Management | 3,450,000 | $25,875,000 | 0.51% |
Vivo Capital, LLC | 786,883 | $5,902,000 | 0.34% |
Ikarian Capital, LLC | 451,531 | $3,387,000 | 0.24% |
Matisse Capital | 50,300 | $377,000 | 0.15% |